Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHAR · BSE: 524632 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹68.97
Market cap: ₹3,032 Cr
Revenue (annual): ₹56.73 Cr
Net profit (annual): ₹22.06 Cr
P/E (TTM): 89.2×Sector 47.4×
Promoter holding: 51.15%+0.19% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Other Announcement 4 Board Meeting Date 4 Financial Results 3 Fund Raise 2 Capital Structure Change 2 Board Meeting Outcome 2 SME to Main Board Migration 1 Merger & Restructuring 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

12 Aug 2026 14:40 IST BSE

Financial ResultsAlfa Alert

Shukra Pharmaceuticals Q1 FY27 Results: Net Profit ₹13 Cr, Up 1200.0% YoY

Shukra Pharmaceuticals Ltd reported revenue from operations of ₹23.5 Cr (+335.2% YoY) and net profit of ₹13 Cr (+1200.0% YoY) for Q1 FY27.

Key figure: Net profit ₹13 Cr · +1200.0% YoY

Open full results → Read the filing ↗

7 May 2026 22:23 IST BSE

Financial Results

Shukra Pharmaceuticals Q4 FY26 Results: Net Loss of ₹1.7 Cr

Shukra Pharmaceuticals Ltd reported revenue from operations of ₹6.3 Cr (-52.6% YoY) and a net loss of ₹1.7 Cr for Q4 FY26.

Key figure: Net loss ₹1.7 Cr

Open full results → Read the filing ↗

7 May 2026 22:22 IST BSE

Financial Results

Shukra Pharmaceuticals Financial Results

Shukra Pharmaceuticals approved FY26 audited financial results and recommended a 1% final dividend. The board also allotted 17.35 lakh equity shares upon warrant conversion.

Read the filing ↗